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Article Summary Line 1 
Based on current trends, almost all African countries are likely to report over 1 000 COVID-19 2 
cases by the end of April 2020, and over 10 000 a few weeks after that. 3 
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For African countries currently reporting COVID-19 cases, we estimate when they will report 19 
more than 1 000 and 10 000 cases. Assuming current trends, more than 80% are likely to exceed 20 
1 000 cases by the end of April 2020, with most exceeding 10 000 a few weeks later.    21 
Main Text 22 
The World Health Organization (WHO) declared COVID-19 a public health emergency of 23 
international concern (1) and then a pandemic (2), citing its rapid global spread and risk of 24 
overwhelming healthcare services with patients requiring critical care. As of 24 March 2020, 25 
WHO situation reports (SITREPs), indicated 45 African countries reported at least one 26 
laboratory-confirmed infection (“reported case”) of COVID--19 (World Health Organization 27 
2020). Reported cases underestimate actual infections due to the mix of mild symptoms (3, 4), 28 
the similarity of symptoms common to the region (5), and weak surveillance (6). However, 29 
assuming constant reporting activity, reported cases grow in proportion to the underlying 30 
epidemic, and even with under-ascertainment of the number of actual cases, reported cases 31 
provide a useful indicator of stress on healthcare systems. We can use this surrogate for the real 32 
epidemic to forecast future trends, and understand the consequences of a slow public health 33 
response and what preparations need to be made now.  34 
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The Study 35 
We use a branching process model to project the number of future cases of COVID-19 in each 36 
country. This model assumes each case produces a number of new cases (distributed 37 
 ~NegBinom  2,   0.58) (7, 8) which occur after some delay (distributed 38 
~LogNormalE  4.7, SD  2.9 (9). We start with cases corresponding to the first 25 39 
(or fewer) reported cases in the WHO SITREPs up to 23 March 2020 (10). Using those epidemic 40 
parameters and initial cases and dates, we simulate the accumulation of the reported cases. We 41 
assume there are always sufficient unreported infections to continue transmission, and that new 42 
cases represent a reporting sample from both identified and unidentified transmission chains. As 43 
long as a constant reporting fraction persists during this period, and unreported spread is large 44 
relative to reported cases (or reporting has negligible impact on control), this is a reasonable 45 
approximation. 46 
For each set of country-specific initial conditions, we generate n=10 000 epidemics, discarding 47 
any that fade out, consistent with our assumption of unreported transmission chains. We identify 48 
the dates when each simulation run crosses 1 000 and 10 000 reported cases, and then evaluate 49 
the 50% and 95% quantiles of those dates to determine the forecast interval. The model was built 50 
in the R statistical programming language, using the bpmodels package (11), and the 51 
data2019nCoV package for the SITREP data (12). All analysis code is available from 52 
https://github. com/SACEMA/COVID10k. 53 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
 is the(which was not peer-reviewed) The copyright holder for this preprint .https://doi.org/10.1101/2020.04.05.20054403doi: medRxiv preprint 
Reserved space. Do not place any text in this section. Include the mandatory author checklist or 
your manuscript will be returned. Use continuous line numbering in your manuscript.  
 
 
We project that almost all African countries are likely to pass 1 000 reported cases by the end of 54 
April 2020 and 10 000 within another few weeks (Figure 1 and Table 1); alarmingly, these are 55 
largely synchronized continent- wide and real disease burden will certainly exceed reported 56 
cases. Since our projections assume failed containment of initial cases and no interventions 57 
reducing early transmission, they are pessimistic relative to any benefits of local action. 58 
However, containment measures, e.g. travel restrictions, increased testing, contact tracing, 59 
isolation of cases and quarantine of contacts, are likely to slow, but not halt, real epidemic 60 
growth (13). Indeed, increased testing may accelerate the time to reporting these numbers, as 61 
improved ascertainment increases the identified fraction of real cases. However, the model also 62 
optimistically assumes surveillance capacity is not overwhelmed or stymied, which would slow 63 
reaching 1 000 reported cases while the real disease burden grows uncontrolled. Because we 64 
ignore these effects, the model is only appropriate for short-range forecasts. 65 
As model validation, we applied this same forecasting approach to countries world-wide that 66 
have now exceeded 1 000 reported cases; we did not consider those with more than 10 000 cases, 67 
as they have all undergone substantial control measures modifying epidemic growth. We found 68 
that 44% of actual reporting dates fell within the 50% prediction intervals, and 79% within the 69 
95% interval (Figure 2), indicating the forecast prediction interval is too certain, as expected for 70 
a rapid but low detail model. We further showed that forecast performance is not a random 71 
outcome by performing a randomization test: we shuffle the assignment of forecast days-to-1 72 
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000-cases to different countries, and score 1 000 shuffled predictions; the real forecast score is 73 
significantly different from random at the p < 0.001 level (Figure 2 inset). 74 
Specific to Africa, the forecast for South Africa fell within the 50% prediction interval (SITREP 75 
69; 29 March 2020). From 23 March 2020, we projected a few other countries would also likely 76 
be crossing this threshold soon: Algeria, Egypt, Morocco, Senegal and Tunisia. As of SITREP 75 77 
(4 April 2020), the first three are still fast approaching this limit, while fast and intense responses 78 
in the latter two may have successfully slowed the epidemic.   79 
Conclusions 80 
Using reporting to date, and assuming similar epidemiological trends to those seen globally, we 81 
project that almost all African countries are likely to exceed 1 000 reported cases by the end of 82 
April 2020, and 10 000 within another few weeks. This timing is largely synchronized continent- 83 
wide and real disease burden will certainly exceed reported cases. Our projections assume no 84 
substantive changes between the initially reported cases and the forecast points; while some 85 
countries have taken drastic actions, many have not or have acted slowly. As seen in other 86 
regions, because onset of severe symptoms can be delayed weeks from infection and last several 87 
weeks, interventions have limited immediate impact on new hospitalizations or facility demand, 88 
meaning that most of the countries in our projection would be well past 1 000 cases by the time 89 
the effects of interventions started today would be observed. 90 
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These results call for accelerated preparations across Africa to ready healthcare systems and 91 
citizens for the incoming wave of COVID-19 infections. Augmented staffing, personal protective 92 
equipment stores and training, general isolation beds and equipped critical care units are all 93 
urgently needed. Citizen awareness will also be critical, and officials should encourage 94 
preventive measures such as physical distancing and regular hand washing.  95 
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Table & Figure Captions 120 
Table 1. Projected Timing of Reporting 1 000 and 10 000 COVID-19 cases for all African 121 
Countries Reporting Cases as of 23 March 2020.  122 
Country / Territory Date of 1K Cases, 50% interval (95%) ...10K Cases 
Algeria Mar 23-Mar 28 (Mar 18-Apr 05) Apr 06-Apr 12 (Apr 01-Apr 20) 
Angola Apr 18-Apr 29 (Apr 12-May 17) May 07-May 21 (Apr 28-Jun 12) 
Benin Apr 15-Apr 26 (Apr 08-May 16) May 03-May 17 (Apr 24-Jun 09) 
Burkina Faso Apr 03-Apr 08 (Mar 31-Apr 15) Apr 18-Apr 23 (Apr 14-May 01) 
Cabo Verde Apr 17-Apr 28 (Apr 11-May 16) May 05-May 20 (Apr 27-Jun 11) 
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Cameroon Apr 02-Apr 08 (Mar 27-Apr 17) Apr 17-Apr 23 (Apr 12-May 03) 
Central African Republic Apr 14-Apr 26 (Apr 07-May 14) May 02-May 18 (Apr 23-Jun 09) 
Chad Apr 17-Apr 29 (Apr 11-May 18) May 06-May 21 (Apr 28-Jun 12) 
Congo Apr 13-Apr 24 (Apr 06-May 13) Apr 30-May 16 (Apr 22-Jun 06) 
Cote d’Ivoire Apr 07-Apr 15 (Apr 02-May 02) Apr 23-May 03 (Apr 16-May 24) 
Democratic Republic of the Congo Apr 05-Apr 10 (Apr 01-Apr 19) Apr 19-Apr 25 (Apr 15-May 06) 
Djibouti Apr 17-Apr 29 (Apr 11-May 18) May 05-May 21 (Apr 27-Jun 12) 
Egypt Mar 20-Apr 07 (Mar 09-Apr 26) Apr 08-Apr 29 (Mar 28-May 22) 
Equatorial Guinea Apr 12-Apr 22 (Apr 06-May 10) Apr 28-May 12 (Apr 21-Jun 04) 
Eritrea Apr 20-May 02 (Apr 11-May 17) May 10-May 24 (May 02-Jun 11) 
Eswatini Apr 15-Apr 26 (Apr 07-May 15) May 02-May 19 (Apr 23-Jun 10) 
Ethiopia Apr 09-Apr 16 (Apr 04-May 01) Apr 23-May 02 (Apr 18-May 26) 
Gabon Apr 12-Apr 23 (Apr 06-May 10) Apr 29-May 13 (Apr 21-Jun 05) 
Gambia Apr 17-Apr 29 (Apr 10-May 19) May 07-May 21 (Apr 28-Jun 12) 
Ghana Apr 05-Apr 10 (Apr 01-Apr 17) Apr 19-Apr 25 (Apr 15-May 03) 
Guinea Apr 14-Apr 26 (Apr 06-May 15) May 01-May 18 (Apr 22-Jun 09) 
Kenya Apr 08-Apr 14 (Apr 03-Apr 24) Apr 23-Apr 30 (Apr 18-May 12) 
Liberia Apr 14-Apr 26 (Apr 08-May 14) May 02-May 17 (Apr 24-Jun 09) 
Madagascar Apr 11-Apr 16 (Apr 08-Apr 25) Apr 25-May 01 (Apr 21-May 11) 
Mauritania Apr 12-Apr 24 (Apr 06-May 14) May 02-May 17 (Apr 23-Jun 07) 
Mauritius Apr 10-Apr 17 (Apr 06-May 01) Apr 25-May 03 (Apr 19-May 25) 
Mayotte Apr 08-Apr 12 (Apr 04-Apr 19) Apr 21-Apr 27 (Apr 17-May 05) 
Morocco Mar 30-Apr 06 (Mar 24-Apr 16) Apr 14-Apr 21 (Apr 08-May 04) 
Mozambique Apr 19-Apr 30 (Apr 13-May 19) May 08-May 23 (Apr 29-Jun 14) 
Namibia Apr 12-Apr 25 (Apr 05-May 13) Apr 30-May 16 (Apr 22-Jun 07) 
Niger Apr 17-Apr 29 (Apr 11-May 19) May 07-May 22 (Apr 28-Jun 12) 
Nigeria Mar 31-Apr 09 (Mar 23-Apr 18) Apr 16-Apr 24 (Apr 09-May 04) 
Reunion Apr 04-Apr 11 (Mar 31-Apr 23) Apr 19-Apr 27 (Apr 14-May 11) 
Rwanda Apr 06-Apr 12 (Apr 02-Apr 22) Apr 21-Apr 28 (Apr 16-May 11) 
Senegal Mar 28-Apr 04 (Mar 23-Apr 12) Apr 11-Apr 18 (Apr 07-Apr 29) 
Seychelles Apr 10-Apr 19 (Apr 05-May 08) Apr 26-May 09 (Apr 20-Jun 02) 
Somalia Apr 15-Apr 27 (Apr 06-May 12) May 05-May 19 (Apr 27-Jun 06) 
South Africa Mar 29-Apr 04 (Mar 26-Apr 15) Apr 12-Apr 19 (Apr 09-May 03) 
Sudan Apr 13-Apr 25 (Apr 05-May 14) Apr 30-May 17 (Apr 22-Jun 08) 
Togo Apr 07-Apr 13 (Mar 30-Apr 19) Apr 21-Apr 27 (Apr 15-May 05) 
Tunisia Mar 30-Apr 04 (Mar 25-Apr 11) Apr 13-Apr 18 (Apr 08-Apr 27) 
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Uganda Apr 15-Apr 23 (Apr 10-May 08) Apr 30-May 10 (Apr 24-May 31) 
United Republic of Tanzania Apr 11-Apr 18 (Apr 06-May 02) Apr 25-May 04 (Apr 20-May 26) 
Zambia Apr 15-Apr 27 (Apr 09-May 15) May 04-May 19 (Apr 25-Jun 11) 
Zimbabwe Apr 17-Apr 28 (Apr 11-May 17) May 07-May 21 (Apr 28-Jun 11) 
 123 
Figure 1. Distribution of times to 1 000 (red to yellow) and 10 000 (grey) cases, with inset map 124 
indicating median expected arrival dates by country (red to yellow, corresponding to time 125 
distributions; countries not reporting cases by 23 March 2020 SITREP in grey).  126 
Figure 2. Forecast validation for countries having already reached 1 000 cases; inset distribution 127 
indicates randomization results for actual forecast (red) versus randomly assigned forecast 128 
(grey), with 0.975 quantile indicated by the line. For actual reporting dates, 44% fell within the 129 
50% prediction intervals, and 79% within the 95%.  130 
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